{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:13:45Z","timestamp":1784157225528,"version":"3.55.0"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jdcr.2024.04.010","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T02:09:06Z","timestamp":1713233346000},"page":"85-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Successful treatment of pityriasis rubra pilaris with brodalumab after nonresponse to IL-17A inhibition: A role for the innate cytokine IL-17C"],"prefix":"10.1016","volume":"48","author":[{"given":"Kailyn","family":"Valido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Leventhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0975-4071","authenticated-orcid":false,"given":"William","family":"Damsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jdcr.2024.04.010_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jid.2021.06.009","article-title":"Pityriasis rubra pilaris response to IL-17A inhibition is associated with IL-17C and CCL20 protein levels","volume":"142","author":"Strunck","year":"2022","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2024.04.010_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jid.2022.09.005","article-title":"Pityriasis rubra pilaris transcriptomics implicate T helper 17 signaling and correlate with response to ixekizumab, with distinct gene expression profiles in nonresponders","volume":"143","author":"Haynes","year":"2023","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2024.04.010_bib3","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/jamadermatol.2020.0932","article-title":"Evaluation of ixekizumab treatment for patients with pityriasis rubra pilaris: a single-arm trial","volume":"156","author":"Haynes","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2024.04.010_bib4","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1111\/ijd.15219","article-title":"Response of pityriasis rubra pilaris to brodalumab after primary failure to ustekinumab","volume":"60","author":"Amat-Samaranch","year":"2021","journal-title":"Int J Dermatol"},{"issue":"7","key":"10.1016\/j.jdcr.2024.04.010_bib5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/ijd.14857","article-title":"Familial pityriasis rubra pilaris successfully treated with brodalumab","volume":"59","author":"De Felice","year":"2020","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2024.04.010_bib6","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1111\/ajd.13215","article-title":"Successful treatment of Pityriasis rubra pilaris with brodalumab","volume":"61","author":"De Rosa","year":"2020","journal-title":"Australas J Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2024.04.010_bib7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jaad.2023.11.017","article-title":"Methotrexate and acitretin in pityriasis rubra pilaris: a retrospective cohort study","volume":"90","author":"Greenzaid","year":"2024","journal-title":"J Am Acad Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624001334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624001334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T15:01:57Z","timestamp":1719068517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512624001334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":7,"alternative-id":["S2352512624001334"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.04.010","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of pityriasis rubra pilaris with brodalumab after nonresponse to IL-17A inhibition: A role for the innate cytokine IL-17C","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}